US Broker Ratings

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Potential 44.88% Upside Fuels Investor Interest

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands out in the biotechnology landscape with a compelling precision medicine approach to oncology. With a market capitalization of $3.02 billion,..

Travere Therapeutics (TVTX) Stock Analysis: Exploring a 40% Upside in Rare Disease Biotechnology

Travere Therapeutics, Inc. (TVTX) is making waves in the biotechnology sector, particularly in the niche of rare kidney and metabolic diseases. With a market cap of..

ImmunityBio, Inc. (IBRX) Stock Analysis: Potential Upside of 90% for This Biotech Innovator

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors with its impressive potential upside of 90%, according to average analyst target prices. As a biotechnology..

Addus HomeCare Corporation (ADUS) Investor Outlook: Assessing the 27.75% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS), a stalwart in the healthcare sector, has caught the attention of investors with its promising potential upside of 27.75%. This figure..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 21.56% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the medical instruments and supplies industry, offers a compelling opportunity for investors seeking exposure to the healthcare..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a 59% Potential Upside in Biotech Innovation

Denali Therapeutics Inc. (DNLI), a trailblazer in the biotechnology sector, is capturing investor attention with its robust pipeline aimed at tackling neurodegenerative and lysosomal storage diseases...

Belite Bio, Inc (BLTE) Stock Analysis: A 14.79% Upside Beckons in the Biotech Sector

Belite Bio, Inc (NASDAQ: BLTE) presents a compelling opportunity in the healthcare sector, particularly for investors with an appetite for biotechnology ventures. Founded in 2016 and..

Certara, Inc. (CERT) Stock Analysis: Unpacking a 22% Potential Upside in the Healthcare Sector

Certara, Inc. (NASDAQ: CERT) stands at the crossroads of healthcare innovation and investment opportunity. As a leader in the health information services industry, Certara offers a..

National HealthCare Corporation (NHC) Stock Analysis: A Closer Look at Its Impressive Revenue Growth and Financial Health

National HealthCare Corporation (NHC), operating in the healthcare sector with a focus on medical care facilities, has garnered attention for its robust revenue growth and financial..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring an 80% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX) is a prominent player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $875.57..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 17% Potential Upside in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biopharmaceutical innovator focused on developing peptide therapeutics for complex blood disorders and inflammatory diseases, stands out in the biotechnology sector..

NovoCure Limited (NVCR) Stock Analysis: An Investor’s Look at 81.53% Potential Upside in the Healthcare Sector

For investors with an eye on the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling opportunity. As a specialist in medical devices, NovoCure focuses on..

PACS Group, Inc. (PACS) Stock Analysis: A Healthcare Standout with 26% Upside Potential

For investors keen on the healthcare sector, PACS Group, Inc. (PACS) presents a compelling opportunity. With a focus on skilled nursing and assisted living facilities, PACS..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Strong Buy Ratings Highlight Potential Upside

For investors seeking opportunities in the healthcare sector, Brookdale Senior Living Inc. (NYSE: BKD) presents an intriguing case. With a market capitalization of $3.04 billion, this..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 27% Upside Potential Amidst Strong Revenue Growth

For investors eyeing opportunities within the biotechnology sector, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents an intriguing prospect. With a market capitalization of $1.68 billion, this U.S.-based..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Look at the 46.90% Potential Upside and Cutting-Edge Genetic Medicine Advancements

Beam Therapeutics Inc. (NASDAQ: BEAM) stands at the forefront of biotechnology innovation with its ambitious focus on precision genetic medicines. Headquartered in Cambridge, Massachusetts, this company..

Kymera Therapeutics (KYMR) Stock Analysis: Exploring a 64% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is a promising name in the biotechnology industry, drawing significant attention from investors due to its innovative approach and strategic partnerships...

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: 14.83% Potential Upside in CNS and Rare Disease Biotech

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a key player in the biotechnology sector, has captured investor attention with its focus on developing treatments for central nervous system..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 28% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector, presents an intriguing opportunity for investors looking to capitalize on its potential upside...

Kiniksa Pharmaceuticals (KNSA): A Promising Biopharma with 27% Upside Potential

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is capturing investor attention with its robust growth trajectory in the biopharmaceutical sector, specializing in developing therapies for cardiovascular diseases and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds